NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 7,680.00
+100.00 (1.32%)
Aug 24, 2026, 3:30 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 93.69 billion as of August 24, 2026. Its market cap has decreased by -28.20% in one year.
Market Cap
93.69B
Enterprise Value
75.47B
Revenue
2.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,680.00
ChartMarket Cap Chart
Since July 25, 2025, NEUROPHET's market cap has decreased from 232.96B to 93.69B, a decrease of -59.78%. That is a compound annual growth rate of -56.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 93.69B | -63.82% |
| Dec 30, 2025 | 258.91B | 11.14% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.72T |
| Celltrion | 44.10T |
| ALTEOGEN | 22.28T |
| Samsung Epis Holdings | 8.94T |
| Vaxcell-Bio Therapeutics | 93.26B |
| Osang Healthcare Co.,Ltd | 91.74B |
| MedPacto | 87.40B |
| iNtRON Biotechnology | 84.80B |